ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.48
0.04 (0.90%)
At close: Aug 15, 2025, 9:50 AM

ENDRA Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.51M -10.06M -13.18M -11.23M
Depreciation & Amortization
206.17K 275.45K 234.26K 224.41K
Stock-Based Compensation
571.92K 996.43K 1.2M 1.44M
Other Working Capital
97.22K -239.11K 222.8K -566.44K
Other Non-Cash Items
3.2M 162.91K 1.39K -298.73K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
134.08K -923.32K -1.03M -1.26M
Operating Cash Flow
-7.4M -9.55M -12.77M -11.12M
Capital Expenditures
-16K -33.88K -202.58K -45K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
3.2K 9.16K n/a n/a
Investing Cash Flow
-12.8K -24.72K -202.58K -45K
Debt Repayment
-28.48K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-5.23K -840 -7.79K -121.07K
Other Financial Acitivies
1.00 1.04M n/a 2.91M
Financial Cash Flow
7.81M 7.52M 8.4M 13.4M
Net Cash Flow
395.57K -2.06M -4.57M 2.23M
Free Cash Flow
-7.42M -9.58M -12.97M -11.17M